Literature DB >> 26872421

Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder.

Paweł Karpiński1, Dorota Frydecka2, Maria M Sąsiadek1, Błażej Misiak3.   

Abstract

Overwhelming evidence indicates that subthreshold inflammatory state might be implicated in the pathophysiology of schizophrenia (SCZ) and bipolar disorder (BPD). It has been reported that both groups of patients might be characterized by abnormal lymphocyte counts. However, little is known about alterations in lymphocyte proportions that may differentiate SCZ and BPD patients. Therefore, in this study we investigated blood cell proportions quantified by means of microarray expression deconvolution using publicly available data from SCZ and BPD patients. We found significantly lower counts of natural killer (NK) cells in drug-naïve and medicated SCZ patients compared to healthy controls across all datasets. In one dataset from SCZ patients, there were no significant differences in the number of NK cells between acutely relapsed and remitted SCZ patients. No significant difference in the number of NK cells between BPD patients and healthy controls was observed in all datasets. Our results indicate that SCZ patients, but not BPD patients, might be characterized by reduced counts of NK cells. Future studies looking at lymphocyte counts in SCZ should combine the analysis of data obtained using computational deconvolution and flow cytometry techniques.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Computational deconvolution; Immunity; Inflammation; Lymphocytes; NK cells; Schizophrenia

Mesh:

Year:  2016        PMID: 26872421     DOI: 10.1016/j.bbi.2016.02.005

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  9 in total

1.  Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

Authors:  Marie Tosolini; Frédéric Pont; Mary Poupot; François Vergez; Marie-Laure Nicolau-Travers; David Vermijlen; Jean-Emmanuel Sarry; Francesco Dieli; Jean-Jacques Fournié
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

Review 2.  Inflammation in CNS neurodegenerative diseases.

Authors:  Jodie Stephenson; Erik Nutma; Paul van der Valk; Sandra Amor
Journal:  Immunology       Date:  2018-04-17       Impact factor: 7.397

Review 3.  Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.

Authors:  Joana Prata; Susana G Santos; Maria Inês Almeida; Rui Coelho; Mário A Barbosa
Journal:  J Neuroinflammation       Date:  2017-09-04       Impact factor: 8.322

4.  Intestinal Microbes in Patients With Schizophrenia Undergoing Short-Term Treatment: Core Species Identification Based on Co-Occurrence Networks and Regression Analysis.

Authors:  Min Xiang; Liqin Zheng; Daoshen Pu; Feng Lin; Xiaodong Ma; Huiqian Ye; Daoqiong Pu; Ying Zhang; Dong Wang; Xiaoli Wang; Kaiqing Zou; Linqi Chen; Yong Zhang; Zhanjiang Sun; Tao Zhang; Guolin Wu
Journal:  Front Microbiol       Date:  2022-06-17       Impact factor: 6.064

Review 5.  High-throughput genomic profiling of tumor-infiltrating leukocytes.

Authors:  Aaron M Newman; Ash A Alizadeh
Journal:  Curr Opin Immunol       Date:  2016-06-30       Impact factor: 7.486

6.  Genetic and environmental influences on circulating NK and T cells and their relation to bipolar disorder.

Authors:  G Snijders; R Brouwer; S Kemner; F Bootsman; H A Drexhage; M H J Hillegers
Journal:  Int J Bipolar Disord       Date:  2019-02-10

Review 7.  120th Anniversary of the Kraepelinian Dichotomy of Psychiatric Disorders.

Authors:  Janusz K Rybakowski
Journal:  Curr Psychiatry Rep       Date:  2019-07-01       Impact factor: 5.285

8.  Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia.

Authors:  Svenja V Trossbach; Laura Hecher; David Schafflick; René Deenen; Ovidiu Popa; Tobias Lautwein; Sarah Tschirner; Karl Köhrer; Karin Fehsel; Irina Papazova; Berend Malchow; Alkomiet Hasan; Georg Winterer; Andrea Schmitt; Gerd Meyer Zu Hörste; Peter Falkai; Carsten Korth
Journal:  Transl Psychiatry       Date:  2019-05-31       Impact factor: 6.222

9.  Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia.

Authors:  Milica M Borovcanin; Slavica Minic Janicijevic; Ivan P Jovanovic; Nevena M Gajovic; Milena M Jurisevic; Nebojsa N Arsenijevic
Journal:  Diagnostics (Basel)       Date:  2020-11-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.